Avia Logo

Compare Products


Jump to:
Categories
Solutions
Description
Compatibility Level
Clients
Use cases
EHR integrations
Client types
Differentiators
Keywords
Media
Company details
Jump to:
Categories
Solutions
Description
Compatibility Level
Clients
Use cases
EHR integrations
Client types
Differentiators
Keywords
Media
Company details
Trials.ai
Trials.ai

0 review

OncoLens
OncoLens

0 review

Categories

Solutions

Description

Product Description:
Trials.ai is leveraging artificial intelligence to fix the two root causes of failure in clinical trials: Study Design & Execution – because patients don’t have time to wait. Every year great research, powerful drugs and innovative devices fail clinical trials because of poor protocols and lack of intelligent tools to conduct trials. Silo'd systems, endless spreadsheets and lack of real-time data wouldn't cut it in other industries, why should healthcare settle? ​Trials.ai is developed with one purpose: to get effective treatments to patients faster by accelerating trials. Our unique approach leverages AI upstream to improve study designs and machine learning to make trial execution smarter, faster and easier for researchers and participants. Based in San Diego, California, Trials.ai launched by Kim Walpole in 2015.
About Trials.ai:
Trials.ai is leveraging artificial intelligence to fix the two root causes of failure in clinical trials: Study Design & Execution – because patients don’t have time to wait. Every year great research, powerful drugs and innovative devices fail clinical trials because of poor protocols and lack of intelligent tools to conduct trials. Silo'd systems, endless spreadsheets and lack of real-time data wouldn't cut it in other industries, why should healthcare settle? ​Trials.ai is developed with one purpose: to get effective treatments to patients faster by accelerating trials. Our unique approach leverages AI upstream to improve study designs and machine learning to make trial execution smarter, faster and easier for researchers and participants. Based in San Diego, California, Trials.ai launched by Kim Walpole in 2015.
Product Description:

More than a hundred community cancer centers IDNs, oncology practices, and health systems count on OncoLens to improve patient access to Next Level Multidisciplinary Cancer Care close to home.

According to the Community Oncology Alliance, 5,000+ community oncologists, practicing in over 950 cancer centers, treat most of the people with cancer in the United States.

OncoLens’ Multidisciplinary Cancer Care Platform supports dedicated oncologists, committed community centers, and the people they serve.

About OncoLens:
OncoLens replaces the current labor intensive process of patient case collaboration and subsequent CoC accreditation in cancer care.

Compatibility level

Select which hospital or health system you work at and see a personalized compatibility level.

Clients

Select which hospital or health system you work at and see the client list

Use Cases

Description:

None provided

Pediatric use cases:

None provided

Users:

None provided

Description:

IDNs and oncology care centers use OncoLens to: 

  • Effectively and accurately manage and coordinate care across healthcare practitioners and facilities to capture the full medical history of patients including data that may be outside the IDN
  • Centralize physician alignment, education, and treatment therapy awareness
  • Coordinate and improve best practices across hospitals, and other facilities, including the dissemination of care pathways
  • Patient identification for clinical trials and other key services from across the network
  • Obtain patient data and informatics in areas ranging from patient leakage and case loss to referral patterns in geographical regions and patient populations

MULTIDISCIPLINARY CARE FOUNDATION

OncoLens Conference

Healthcare practitioners and facilities that are a part of an IDN need to manage and coordinate patients care effectively and accurately.

  • Captures the full medical history of the patients
  • Automatically identifies best practice protocols for the patient under discussion—including evidence-based guidelines, clinical trials, customized pathways, and latest research—and delivers these insights directly within the workflow
  • Eliminates the back and forth required with pathology and radiology by automating the data collection workflow
  • Streamlines administrative tasks, automatically marking and generating attendance reports required for accreditation
  • Prompts the team to consider the various quality metrics important to the condition being discussed
  • Supports the development and dissemination of disease specific care pathways and protocols across the network

OncoLens Collaborate

Enables asynchronous submission and case review and supports sharing of multiple modalities, including PACS studies, pathology images, and test results.

Secure, real-time patient case collaboration, inside and outside of your Oncology program, builds relationships that can:

  • Centralize control of physician and patient data
  • Improve physician engagement and alignment
  • Double guideline adherence
  • Increase clinical trial participation

INTEROPERABILITY

OncoLens Integrate

The Integrate module delivers EMR and Cancer Registry integration.

This unprecedented combination of clinical and cancer conference data supports ease of accreditation reporting for Commission on Cancer (CoC), National Accreditation Program for Breast Centers (NAPBC), National Accreditation Program for Rectal Cancer (NAPRC).

With EMR integration, cancer care teams have an all-inclusive view of a patient including clinical, lab, genomic and imaging information to support clinical decisions.

OncoLens Secure SSO

OncoLens Secure SSO enables single sign on (SSO) capabilities through your active directory. SSO authentication is a clear win for clinicians.

Not only does it enhance security, it:

  • Facilitates technology adoption across clinicians
  • Streamlines the workflow
  • Supports and ensures compliance
  • Amplifies automation across systems
  • Helps improve clinicians’ perceptions of technology deployments and IT

OncoLens Image Share

One of the biggest barriers to multidisciplinary treatment planning is the ability to securely share radiology studies with peers and care team members. For cancer programs that require enhanced capabilities to upload, share, store, and comment on digital images, we offer OncoLens Image Share.

This module enables DICOM image imports from local drives, PACS, CDs, or through a direct gateway. Images are viewed through our web-based 510(k) FDA class II diagnostic viewer, which is fully integrated into the OncoLens Platform.

INFORMATICS AND ACCREDITATIONS

OncoLens Analyze and Patient Finder

OncoLens Analyze and Patient Finder solutions help cancer programs find a shorter and more rapid path to accreditation, clinical trial matching and quality improvement.

Our accreditation solutions include standardized, automated, and downloadable reports for CoC, NAPBC and NAPRC accreditation.

This module gives you the visibility into key hidden metrics within your clinical data. Data that can be powerful when aggregated to provide insights. These include assessments of factors such as:

  • Time from diagnosis to case review
  • Percentage of patients with biomarker testing and results at the time of initial treatment planning
  • Number of patients referred to clinical trials
  • Time from case review and treatment planning to treatment initiation
  • Number of multidisciplinary team discussions during treatment
  • Number of patients referred to key services like CAR-T and specialty therapies

OncoLens Molecular

Easily engage molecular pathologists, specialists, and external experts to guide and inform precision medicine discussions. Genomic data from NGS (next generation sequencing) reports can often be hard to interpret and visualize clearly. OncoLens Molecular assists in the clearer visualization and assessment of genomic data, alongside the patient’s clinical data and studies.

With OncoLens Molecular, care teams can:

  • View integrated NGS test results in structured fields
  • Harness the power of their prior treatment plans and discussions to guide future decisions
  • Easily engage molecular pathologists and external experts to guide case discussions
  • View best practices and links to actionable therapies narrowed down by alteration/variant type
  • View clinical trial matches from OncoLens’ AI driven clinical trial matching engine or those suggested by NGS partners
Pediatric use cases:

None provided

Users:
  • Ascension Lourdes
  • Harold Leever Regional Cancer Center
  • MaineGeneral Medical Center
  • Wellstar Health System 

EHR Integrations

Integrations:

None provided

EMR Integration & Relevant Hardware:

None provided

EMRs Supported:

None provided

Hardware Compatibility:

None provided

Integrations:

Acute care EMR, Ambulatory EMR, Ancillary EMR

EMR Integration & Relevant Hardware:

Required

EMRs Supported:

Epic, Cerner, Meditech

Hardware Compatibility:

Desktop

Client Types

None provided
None provided

Differentiators

Differentiators vs EHR Functionality:

None provided

Differentiators vs Competitors:

None provided

Differentiators vs EHR Functionality:

None provided

Differentiators vs Competitors:

None provided

Keywords

Images

No images provided

No images provided

Videos

No videos provided

No videos provided

Downloads

No content provided

No content provided

Alternatives

Company Details

Founded in 2016

Founded in 2016

team illustration
Share your product comparison with your collegues.

Need help narrowing down products?

Add more criteria to see your compatibility level for every vendor. It only takes a few minutes, just create a free account to get started.
back to top